The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Major > Novartis AG

Novartis AG
NYSE: NVS
Change
symbol:
     
 NEWS FROM THE WIRES
ADR REPORT-Foreign shares gain ground ahead of Fed
Aug 21 2001 09:35 AM PDT

Bristol picks up Bayer's cholesterol drug market
Aug 20 2001 12:26 PM PDT

ADR REPORT - Tech shares hit by economic, profit jitters
Aug 16 2001 08:48 AM PDT

ADR REPORT - Tech shares hit by economic, profit jitters
Aug 16 2001 08:48 AM PDT

Rigel in deal with Novartis to find cancer drugs
Jul 31 2001 08:28 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
FDA Catches Fed's Disease
Jul 11 2001 06:21 AM PDT

Designer Drugs
May 21 2001 12:00 AM PDT

Betting on a Biotech Longshot
Mar 26 2001 12:00 AM PST

Lesson No. 1: A Negotiation Is Not a Deal
May 29 2000 12:00 AM PDT

World Online's Excellent Adventure
Mar 27 2000 12:00 AM PST

 PROFILE
Novartis (derived from "novae artes", which is Latin for "new skills") is the world's top pharmaceutical firm (by sales). Prescription drugs, including hypertensives Diovan and Lotrel and transplant drug Neoral, comprise some 60% of the firm's revenues. Novartis' consumer health unit includes such brands as Gerber baby foods, ExLax, Maalox, Tavist, and Theraflu and generates nearly one-fourth of revenues. The company also makes and sells contact lenses and eye care products (CIBA Vision and Novartis Ophthalmics), animal health products, and generic pharmaceuticals. Novartis spun off its agrichemicals unit and combined it with AstraZeneca's to form stand-alone company Syngenta.

 COMPETITION
Johnson & Johnson (JNJ)
Merck & Co., Inc. (MRK)
Pfizer Inc (PFE)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 40,789.00
1-Yr. Sales Growth: 99.8%
Employees: 68,000
Revenue per employee: $599,838.24

 KEY PEOPLE

• Raymund Breu
    CFO

 CONTACT INFO
Lichtstrasse 35
CH-4056 Basel, Switzerland
Phone: 41-61-324-1111
Fax: 41-61-324-8001
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001